ESR1 and breast carcinoma: Moreover, tau was able to obstruct the binding of taxane [3] and paclitaxel [16] to the inner surface of microtubules, and thus reduced the sensitivity of breast cancer tissues with expression of estrogen receptors (ER) to these drugs, showing a promoting role of tau in tumor growth.